The construction of genetically encoded cellular mimics in compartments containing organized synthetic cytosols is desirable for the development of artificial cells. Phase separated aqueous domains were placed within water-in-oil emulsion droplets in a manner compatible with transcription and translation machinery. Aqueous two-phase and three-phase systems (ATPS and A3PS) were assembled with dextran, poly(ethylene glycol), and Ficoll. Aqueous two-phase systems were capable of supporting the cell-free expression of protein within water droplets, whereas the aqueous three-phase-based system did not give rise to detectable protein synthesis. The expressed protein preferentially partitioned to the dextran-enriched phase. The system could serve as a foundation for building cellular mimics with liquid organelles.
The construction of genetically encoded cellular mimics in compartments containing organized synthetic cytosols is desirable for the development of artificial cells. Phase separated aqueous domains were placed within water-in-oil emulsion droplets in a manner compatible with transcription and translation machinery. Aqueous two-phase and three-phase systems (ATPS and A3PS) were assembled with dextran, poly(ethylene glycol), and Ficoll. Aqueous two-phase systems were capable of supporting the cell-free expression of protein within water droplets, whereas the aqueous three-phase-based system did not give rise to detectable protein synthesis. The expressed protein preferentially partitioned to the dextran-enriched phase. The system could serve as a foundation for building cellular mimics with liquid organelles.
Cellular life is organized
on many levels. Several metabolic processes
follow a cyclic, circadian rhythm, and the behavior of cellular populations
emerges from the coordinated activity of individual cells. Within
the cell, various forms of spatial organization help drive cellular
chemistry. Membrane bound organelles, protein microcompartments, and
transiently forming metabolons all facilitate metabolic flux down
desired paths.[1] Protein lipidation increases
the likelihood that cognate proteins interact by restricting diffusion
to the two-dimensional space of the membrane. Similarly, preferential
partitioning to specific aqueous phases can lead to significant enhancements
in enzymatic activity.[2] Although the latter
example of aqueous phase separation has not been extensively investigated
in biological systems, mixtures of aqueous polymer solutions do phase
separate in vitro,[3] inside of living cells,[4] and were likely present from the earliest stages
of evolution.[5] Therefore, it seems probable
that contemporary cells exploit these “liquid organelles”
to facilitate metabolic chemistry.[6]One approach toward gaining insight into the organizational features
of cellular life is to construct mimetic systems in the laboratory
that display similar organization and behavior.[7,8] Several
recent studies have defined a set of chemical conditions that give
rise to two coexisting aqueous phases in lipid vesicles.[9,10] Others demonstrated that transcription–translation (T/T)
can be carried out in vesicles[11] and in
bulk aqueous two-phase systems (ATPS).[12,13] By combining
these approaches, it should be possible to produce genetically encoded
proteins that distribute between coexisting phases as a model for
cellular microcompartments.In most traditional giant vesicle
preparation strategies (i.e.,
those that do not involve a water-in-oil (w/o) emulsion step), macromolecule
encapsulation efficiency is low and varies considerably from vesicle-to-vesicle
within a batch.[14−17] This can be understood in terms of the low fraction of total volume
that is encapsulated within the vesicle population; generally the
vast majority of the aqueous solution volume is outside of the vesicles,
with ≪1% inside the vesicles.[11] Additionally,
macromolecules are generally encapsulated at concentrations less than
would be anticipated based on their external concentrations during
vesicle formation.[18] These problems are
compounded when encapsulating the over 100 components needed for T/T.
Although recent studies have shown that a few individual vesicles
within a population can encapsulate all of the necessary components
for protein expression, most vesicles in the population are not competent
for transcription–translation.[14,15] Polymer condensation
due to macromolecular crowding does facilitate encapsulation, but
the majority of total solute molecules still remain outside the vesicles.[18,19] For vesicles formed by gentle hydration or electroformation, encapsulation
of ATPS requires making vesicles under conditions where the system
exists as a single phase by, for example, heating or diluting the
solution. After vesicle formation, the sample is cooled or concentrated,
respectively.[5] Alternatively, microfluidic-based
protocols were developed to permit control over the volume and contents
of droplets in oil.[20] Recently, osmotically
driven phase separation in cell lysate droplets produced coacervates
capable of accommodating T/T.[21] Despite
these advances, direct encapsulation of more than two phases enriched
in different polymers—which poses additional challenges for
both phase-transition and microfluidic approaches—has not been
demonstrated.To construct cellular mimics containing organized
artificial cytosols
and functional T/T machinery, the use of w/o emulsions was explored.
Unlike the inefficiency of encapsulation in vesicles, w/o emulsions
give nearly complete encapsulation, meaning that the internal aqueous
conditions faithfully represent the starting aqueous phase. Therefore,
the position on the phase diagram is known, and the properties of
the phases, such as solute partitioning, interfacial tensions, and
viscosity, can be acquired from bulk measurements. Nevertheless, it
was unclear whether simply replacing the water in a w/o emulsion recipe
with a preformed ATPS or aqueous three-phase system (A3PS) would result
in the encapsulation of multiple phases within each droplet of the
emulsion or a mixture of single-phase droplets that contain the different
phases.Herein we describe a simple method to generate aqueous
multiphase
systems within w/o droplets that is compatible with T/T and does not
require the use of a microfluidic device. A phase-separated polymer
solution was used in place of the aqueous portion of a traditional
w/o droplet-generating protocol based on mechanical mixing of aqueous
solution and mineral oil in the presence of a standard surfactant
mixture.[22,23] Surfactant-stabilized droplets containing
ATPS and A3PS with dextran, poly(ethylene glycol) (PEG), and Ficoll
were produced in this manner. T/T was performed and efficiently produced
fluorescent protein in the ATPS droplets. This platform could serve
as a foundation for genetically encoded targeting to liquid organelles
within the cytosolic space of artificial cells.
Results and Discussion
A standard w/o emulsion composition of 4.5% (v/v) Span 80, 0.5%
(v/v) Tween 80 in 0.95 mL of mineral oil[23], and 50 μL of an ATPS consisting of 10% (w/w) dextran 10 kDa
and 7% (w/w) PEG 8 kDa was chosen to evaluate the potential of w/o
droplets in encapsulating multiple aqueous phases.[9] [Note: surfactant and polymer percent concentrations are
given in (v/v) and (w/w), respectively.] In bulk samples of this ATPS,
the PEG-rich phase volume is approximately four times larger than
that of the dextran-rich phase; mechanical mixing generates a cloudy
dispersion of one phase in the other. A room-temperature aliquot of
a well-mixed ATPS in which both phases were present as a dispersion
was added to mineral oil that contained the surfactant mixture and
vortexed to generate an emulsion. Optical microscopy revealed that
91 ± 2% of 233 droplets contained both PEG-rich and dextran-rich
aqueous phases, surrounded by mineral oil (Figure 1, Figure S1A). Droplets were not
identical in size nor composition, reflecting a distribution of encapsulated
ATPS phase volumes. In contrast, hydrating lipids in an ATPS with
vortexing produced only vesicles with a single aqueous phase in the
internal volume (Figure S2).
Figure 1
Optical microscope
images of w/o emulsion droplets containing a
PEG/dextran ATPS. A single droplet is shown in A, and a wider view
with several droplets is shown in B. Images on the left and right
are transmitted (DIC) and confocal fluorescence channels, respectively.
ATPS: 10% dextran 10 kDa, 7% PEG 8 kDa. Labeled polymers were added
to aid visualization of the phases: Alexa 488 labeled PEG 5 kDa (false-colored
green) and Alexa 647 labeled dextran 10 kDa (false-colored blue).
Scale bar = 10 μm.
Optical microscope
images of w/o emulsion droplets containing a
PEG/dextranATPS. A single droplet is shown in A, and a wider view
with several droplets is shown in B. Images on the left and right
are transmitted (DIC) and confocal fluorescence channels, respectively.
ATPS: 10% dextran 10 kDa, 7% PEG 8 kDa. Labeled polymers were added
to aid visualization of the phases: Alexa 488 labeled PEG 5 kDa (false-colored
green) and Alexa 647 labeled dextran 10 kDa (false-colored blue).
Scale bar = 10 μm.Next, two additional polymer compositions chosen to fall
on or
near the same tie-line were encapsulated in w/o droplets so that the
phase compositions would be similar to the ATPS described above but
differ in relative volume.[6] Relative phase
volume in the bulk ATPS may influence the ability to encapsulate both
phases within an emulsion droplet and/or the relative sizes of the
resulting encapsulated phase microcompartments. The two new compositions
were 19.8% dextran, 2.8% PEG and 18.5% dextran, 5.5% PEG, resulting
in larger volume dextran phases (ca. 30 and 40% of the total bulk
aqueous volume, respectively). Increasing the dextran phase only slightly
to ∼30% of the total aqueous volume had no observable effect
on encapsulation efficiency, with 88% of 201 droplets containing both
aqueous phases. However, increasing the volume of the dextran-enriched
phase further to 40% resulted in a drop in ATPS encapsulation efficiency
to 58% (177 droplets evaluated). The three different ATPS in w/o droplets
were similar morphologically, with variability between individual
droplets within a batch (Supporting Information,
Figure S1A,B,C). Within droplets, the ATPS phases were either
side-to-side so that each aqueous phase interfaced with both the oil-surfactant
phase and the other aqueous polymer phase, or concentric with one
phase surrounding the other and in contact with the oil–surfactant
phases. Some of the droplets assumed a non spherical, budding morphology
similar to that previously observed with ATPS-containing vesicles.[5,10] The relative volumes of each phase were heterogeneous but generally
consistent with the starting aqueous compositions in the sense that
ATPS compositions with a greater dextran volume, for example, typically
showed droplets with a larger dextran enriched aqueous phase than
ATPS compositions with a smaller dextran volume.We next sought
to determine whether the same method could be exploited
to produce an A3PS inside of w/o droplets. A3PS consisting of 19.8%
dextran 10 kDa, 2.8% PEG 8 kDa, 5% Ficoll 400 kDa was vortexed with
mineral oil containing 4.5% Span 80, 0.5% Tween 80. Three aqueous
phases were clearly visible in the droplets (Figure 2, Figure S3). The Ficoll-rich phase
was found between the PEG-rich and dextran-rich phases, consistent
with its position in bulk A3PS. The efficiency of the process was
similar to that of ATPS with 86% of 227 water droplets containing
all three aqueous phases. The assembly of analogous A3PS vesicles,
e.g., by gentle hydration of lipids, would be significantly more difficult
and to our knowledge has never been demonstrated. A3PS droplets in
Figure 2 show an interfacial accumulation of
the labeled dextran used for visualization. This may be due to interactions
between the polymer(s) and surfactants.[24] Span 80 and Tween 80 are appreciably soluble in oil and water,[25] respectively, and likely were not fully localized
to the interface. The fluorescent dextran used in these experiments
was larger (40 kDa) than the majority of the dextran that makes up
this phase (10 kDa), which may contribute to its different interfacial
partitioning.
Figure 2
A3PS in w/o emulsion droplets. A3PS consisted of 19.8%
dextran,
2.8% PEG, and 5% Ficoll. Transmitted light (left) and fluorescence
(right) microscopy images are shown. Aqueous phases were visualized
with Alexa 488 labeled PEG (green) and Alexa 647 labeled dextran 40
kDa (blue). Scale bar = 10 μm.
A3PS in w/o emulsion droplets. A3PS consisted of 19.8%
dextran,
2.8% PEG, and 5% Ficoll. Transmitted light (left) and fluorescence
(right) microscopy images are shown. Aqueous phases were visualized
with Alexa 488 labeled PEG (green) and Alexa 647 labeled dextran 40
kDa (blue). Scale bar = 10 μm.To gain insight into whether aqueous multiphase encapsulation
efficiency
was related to the properties of the oil–water interface, w/o
emulsions were prepared using a different surfactant composition.
Decreasing Span 80 from 4.5% to 2% and increasing Tween 80 from 0.5
to 3% resulted in stable emulsions over the time course of the experiments;
however, the droplets no longer efficiently entrapped the two aqueous
phases. Droplets only possessed dextran or PEG enriched phases but
not both (Figure S4). Although the oil–water
interface likely contributes to the behavior of the system as a whole,
other factors may be of importance; the surfactants may influence
the phase behavior and/or solubility of the polymers in the aqueous
and oil phases.[18]We next attempted
to construct cellular mimetic droplets with an
artificial, phase separated cytoplasm. ATPS and A3PS were assembled
on ice and diluted 2-fold with DNA and the PURE system,[26] consisting of T7 RNA polymerase and Escherichia coli translation machinery. The DNA coded
for monomeric yellow fluorescent protein (mYPet).[27] An aliquot of the aqueous solution was then used to generate
the w/o emulsion. In this setup, ATPS encapsulation efficiency was
lower (23% of 276 droplets) because of dilution with T/T machinery.
Therefore, the starting polymer solutions were doubled in concentration
so that the 2-fold dilution with the T/T components would bring the
polymer concentrations back to the levels that gave high efficiency
encapsulation. This method significantly improved the efficiency of
two-phase encapsulation and consequently increased our ability to
see expression in two-phase droplets. After incubation at 37 °C
for 2 h, fluorescence microscopy showed protein expression in two
of the three ATPS emulsion systems (Figure 3, Figure S5–S9). ATPS-containing
droplets with mYPet fluorescence made up 49% and 66.5%, respectively,
of all droplets in 10% dextran 10 kDa/7% PEG 8 kDa (216 droplets counted)
and 19.8% dextran 10 kDa/2.8% PEG 8 kDa (230 droplets). The ATPS that
failed to support protein expression was also the least efficient
in coentrapment within w/o droplets, i.e., 18.5% dextran, 5.5% PEG.
Protein expression was not observed in A3PS. This may be due to the
greater similarity between the two polysaccharide-enriched phases,
i.e., Ficoll and dextran. It is possible that some T/T components
that were colocalized in the dextran-rich phase of the PEG/dextranATPS were localized to different phases in the A3PS. In other words,
in the exploited ATPS compositions, partitioning was between a hydrophilic
polysaccharide (dextran) and a more hydrophobic poly(ethylene oxide)
(PEG). Under such conditions, T/T machinery would be expected to preferentially
partition to the less hydrophobic dextran phase. In the A3PS there
was more than one such phase. We anticipate that further optimization,
e.g., reducing the collective volumes of the dextran-rich and Ficoll-rich
phases, or replacing the Ficoll-rich phase with a different third
phase more chemically distinct from the dextran-rich phase, could
ultimately enable expression in an A3PS.
Figure 3
Cell-free protein expression
inside of w/o droplets containing
an ATPS. The ATPS and w/o emulsions were prepared at room temperature
and contained T/T machinery and DNA encoding the fluorescent protein
mYPet. Reactions were initiated by incubation at 37 °C. The ATPS
was (A) 10% dextran, 7% PEG and (B) 19.8% dextran, 2.8% PEG. From
left to right, the images are transmitted light (DIC), the fluorescence
of expressed mYPet, and the fluorescence of Alexa 647-labeled dextran
10 kDa. Expression was either for 4 h (A) or 6 h (B). The expressed
protein preferentially partitioned to the dextran-enriched phase.
Scale bars are 50 μm (A) and 25 μm (B).
Cell-free protein expression
inside of w/o droplets containing
an ATPS. The ATPS and w/o emulsions were prepared at room temperature
and contained T/T machinery and DNA encoding the fluorescent protein
mYPet. Reactions were initiated by incubation at 37 °C. The ATPS
was (A) 10% dextran, 7% PEG and (B) 19.8% dextran, 2.8% PEG. From
left to right, the images are transmitted light (DIC), the fluorescence
of expressed mYPet, and the fluorescence of Alexa 647-labeled dextran
10 kDa. Expression was either for 4 h (A) or 6 h (B). The expressed
protein preferentially partitioned to the dextran-enriched phase.
Scale bars are 50 μm (A) and 25 μm (B).
Conclusions
Cellular life is organized
to an extent that has yet to be well
mimicked by artificial, bottom-up constructions. Part of the problem
thus far has been an incompatibility between some biological molecules
and aqueous organization methods that rely on lengthy protocols or
heating steps.[9] W/o emulsions overcome
many of these problems by not requiring a heating step, by being extremely
efficient in encapsulating molecules, and by necessitating little
time to implement. This is important because of the fragility of the
T/T machinery of the PURE system, which loses activity at 37 °C
within 3 h.[28,29] Here we have shown that ATPS
and A3PS can be encapsulated with high efficiency within w/o droplets
stabilized with commonly exploited surfactants. Therefore, routinely
used w/o emulsion generation protocols are compatible with the encapsulation
of multiple aqueous phases. Further, specific ATPS compositions are
capable of converting the information encoded in DNA to functional
protein, and the expressed protein preferentially partitioned to a
specific aqueous phase. Consequently, it should be possible to build
artificial cells with genetically encoded targeting to liquid organelles
in the future. Also, since w/o emulsions can be stabilized with natural
lipids in place of synthetic surfactants and that such emulsion droplets
can be converted to vesicles,[30] the methodology
described herein should be modifiable for the generation of vesicles
containing aqueous multiphase systems compatible with T/T machinery.
Authors: B V V S Pavan Kumar; James Fothergill; Joshua Bretherton; Liangfei Tian; Avinash J Patil; Sean A Davis; Stephen Mann Journal: Chem Commun (Camb) Date: 2018-04-05 Impact factor: 6.222
Authors: Emilien Dubuc; Pascal A Pieters; Ardjan J van der Linden; Jan Cm van Hest; Wilhelm Ts Huck; Tom Fa de Greef Journal: Curr Opin Biotechnol Date: 2018-12-26 Impact factor: 10.279